Artemis Medicare Q4 FY26: Revenue Up 16.4%, PAT Up 32.1%
Artemis Medicare Services Ltd. reported a 16.4% YoY increase in consolidated revenue to ₹27,923 Lacs for Q4 FY26. PAT surged 32.1% to ₹3,028 Lacs. For FY26, consolidated revenue grew 15.4% to ₹1,08,124 Lacs, with PAT up 26.2% to ₹10,372 Lacs. The company is also progressing on its upcoming Raipur facility.
The announcement details substantial financial growth and provides insights into operational performance and future expansion plans, which are material to investors.
The company reported significant year-over-year growth in revenue, EBITDA, and net profit for both the quarter and the full fiscal year, indicating strong financial performance.
Artemis Medicare Services Ltd. announced its financial results for the quarter and year ended March 31, 2026. On a consolidated level, the company registered a revenue from operations of ₹27,923 Lacs for Q4 FY26, an increase of 16.4% compared to the same period last fiscal year. EBITDA saw a growth of 23.1% to ₹5,938 Lacs, and Profit After Tax (PAT) increased by 32.1% to ₹3,028 Lacs.
For the full fiscal year FY26, consolidated revenue from operations grew by 15.4% to ₹1,08,124 Lacs. EBITDA increased by 18.0% to ₹21,801 Lacs, and PAT rose by 26.2% to ₹10,372 Lacs.
The company's flagship Gurugram facility also showed strong performance. For Q4 FY26, revenue from operations increased by 18.8% to ₹26,746 Lacs, with EBITDA growing by 20.6% to ₹5,804 Lacs and PAT up by 19.8% to ₹3,136 Lacs. For the full FY26, revenue from operations for the Gurugram facility was ₹1,03,022 Lacs, up 17.8%, while EBITDA grew by 17.2% to ₹21,785 Lacs and PAT increased by 15.2% to ₹11,336 Lacs.
Commenting on the performance, Chairman Mr. Onkar Kanwar highlighted the steady progress, consistent execution, and focus on high-quality clinical outcomes. He noted the strong performance of the Gurugram facility, driven by a strong case mix, stable occupancy, and growing contribution from international patients. Dr. Devlina Chakravarty, Managing Director, mentioned operational discipline and ongoing efficiency initiatives supporting improved profitability. She also provided an update on the upcoming Raipur facility, which is progressing well and represents an important step in extending the company's presence into new, high-growth markets.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.